Resveratrol induces apoptosis in LNCaP cells and requires hydroxyl groups to decrease viability in LNCaP and DU 145 cells
- 19 July 2002
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 52 (4), 319-329
- https://doi.org/10.1002/pros.10122
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- International trends and patterns of prostate cancer incidence and mortalityInternational Journal of Cancer, 2000
- Differential Effects on Growth, Cell Cycle Arrest, and Induction of Apoptosis by Resveratrol in Human Prostate Cancer Cell LinesExperimental Cell Research, 1999
- Resveratrol: A molecule whose time has come? And gone?Clinical Biochemistry, 1997
- Cellular interactions in prostate cancerBritish Journal of Urology, 1997
- Induction of Apoptosis by Diethylstilbestrol in Hormone-Insensitive Prostate Cancer CellsJNCI Journal of the National Cancer Institute, 1996
- Current Concepts in the Treatment of Cancer of the ProstatePublished by Springer Science and Business Media LLC ,1996
- Estrogens in the Treatment of Prostate CancerJournal of Urology, 1995
- Apoptosis: Mechanisms and Roles in PathologyPublished by Elsevier BV ,1991
- A mutation in the ligand binding domain of the androgen receptor of human INCaP cells affects steroid binding characteristics and response to anti-androgensBiochemical and Biophysical Research Communications, 1990
- Diethylstilbestrol in the prevention and treatment of complications of pregnancyAmerican Journal of Obstetrics and Gynecology, 1948